European Chamber Pharmaceutical Working Group Chair Presents China’s Healthcare Policy Review at the EU Delegation to China

2019-05-13 | Beijing, Shanghai

On 14th May, Ms. Li Ye, National Chair of the Pharmaceutical Working Group, gave a presentation on China’s Healthcare Policy Review at the EU Delegation to China. Representatives from Member States (France, Denmark, UK and Sweden) and the Trade and Health officials of the EU Delegation attended the meeting.

Ms. Li's presentation touched upon the major challenges that the foreign pharmaceutical companies are currently facing in China, including the increased payment pressure of medical insurance fund, lack of a transparent and fair process for China National Reimbursement Drug List updating, volume-based procurement pilot, rare disease policy, health technology assessment, etc. The presentation was followed by a one-hour discussion with the participants.